Calmare Therapeutics Price on November 28, 2022

CTTCDelisted Stock  USD 0.0001  0.00  0.00%   
If you're considering investing in Calmare Stock, it is important to understand the factors that can impact its price. As of today, the current price of Calmare Therapeutics stands at 0.0001, as last reported on the 18th of December 2024, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found eighteen technical indicators for Calmare Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Calmare Therapeutics' Risk Adjusted Performance of 0.2234, standard deviation of 290.29, and Mean Deviation of 165.8 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Calmare Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CTTC
Based on monthly moving average Calmare Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Calmare Therapeutics by adding Calmare Therapeutics to a well-diversified portfolio.

Calmare Therapeutics Valuation on November 28, 2022

It is possible to determine the worth of Calmare Therapeutics on a given historical date. On November 28, 2022 Calmare was worth 2.0E-4 at the beginning of the trading date compared to the closed value of 2.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Calmare Therapeutics stock. Still, in general, we apply an absolute valuation method to find Calmare Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Calmare Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Calmare Therapeutics' related companies.
 Open High Low Close Volume
11/28/2022
  0.0002    0.0002    0.0002    0.0002    5,300  
  0    0    0    0    500.00  
Backtest Calmare Therapeutics  |  Calmare Therapeutics History  |  Calmare Therapeutics Valuation Next  
Open Value
2.0E-4
2.0E-4
Closing Value
0.00
Upside

Calmare Therapeutics Trading Date Momentum on November 28, 2022

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Calmare Therapeutics Fundamentals Correlations and Trends

By evaluating Calmare Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Calmare Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Calmare financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Calmare Therapeutics Stock history

Calmare Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Calmare is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Calmare Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Calmare Therapeutics stock prices may prove useful in developing a viable investing in Calmare Therapeutics
Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut. Calmare Therapeutics operates under Medical Devices classification in the United States and is traded on NYSEMKT Exchange. It employs 7 people.

Calmare Therapeutics Stock Technical Analysis

Calmare Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Calmare Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Calmare Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Calmare Therapeutics Period Price Range

Low
December 18, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Calmare Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Calmare Therapeutics December 18, 2024 Market Strength

Market strength indicators help investors to evaluate how Calmare Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Calmare Therapeutics shares will generate the highest return on investment. By undertsting and applying Calmare Therapeutics stock market strength indicators, traders can identify Calmare Therapeutics entry and exit signals to maximize returns

Calmare Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Calmare Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Calmare Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Calmare to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Calmare Stock

If you are still planning to invest in Calmare Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calmare Therapeutics' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years